Oxford Biodynamics company

Oxford BioDynamics Plc (AIM: OBD) ("Oxford BioDynamics") is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The Company’s award-winning, proprietary technology platform, EpiSwitch™, aims to accelerate the drug discovery and development process, improve the success rate of therap.
Technology: biomarkers
Industry: Personalized Medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2007
Employees Number: Undisclosed
Funding Status: IPO
Investors Number: 1
Total Funding: £9.8M
Estimated Revenue: Less than $1M
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership